Take Control of Your Diabetes Risk With Dr. John Whyte, MD, MPHMay 25, 2022
John Whyte, MD, MPH is the Chief Medical Officer, WebMD. In this role, Whyte leads efforts to develop and expand strategic partnerships that create meaningful change around important and timely public health issues.
Prior to WebMD, Whyte served as the director of professional affairs and stakeholder engagement at the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Whyte worked with health care professionals, patients, and patient advocates, providing them with a focal point for advocacy, enhanced two-way communication, and collaboration, assisting them in navigating the FDA on issues concerning drug development, review, and drug safety.
In this episode, Dr. Whyte dives into the importance of lifestyle changes on our health and how lifestyle is one of the most significant causes of cancers, diabetes, and other non-communicable disease.
Listen to This Episode
Highlights From This Episode
[0:00] Topic Intro
[03:30] Challenges that arise with innovation in medicine.
[06:20] How Dr. Whyte’s practice has changed over the years.
[11:55] The different pillars of health that are impacting our wellness.
[20:05] How Dr. Whyte optimizes his sleep habits and sleep hygiene tips.
[32:55] Most cancers are caused by a combination of lifestyle issues.
[38:50] The importance of recognizing mental health and how to navigate depression and anxiety.
[43:20] Exercise recommendations from Dr. Whyte.
Subscribe & Review
Subscribing and leaving a rating and review are important factors in helping the Reshape Your Health Podcast and the YouTube Channel reach more people. If you haven't already subscribed, please do that today.
We would also be grateful if you left a rating and review, too. In your listening app, scroll to the “Ratings and Reviews” section, then click “Write a Review” and let us know what you enjoy about our show. We appreciate you taking the time to show your support. Thank you!
Resources From This Episode
>> Join Zivli